7
Views
2
CrossRef citations to date
0
Altmetric
Original Papers

Factors Determining the Post-Operative Hypo-Albuminaemia in Cancer Patients-Stepwise Regression Analysis

, , , , , & show all
Pages 287-292 | Published online: 14 Mar 2016

References

  • Wigmore S. J., McMahon A. J., Sturgeon C. M., Fearon K. C. H. Acute phase protein response, survival and tumour recurrence in patients with colorectal cancer. Brit J Surgery, 2001, 88: 255–260.
  • Barber M. D., Ross J. A., Fearon K. C. H. Cancer cachexia. Surg Oncol, 1999, 8: 133–141.
  • Kulpa J., Duda K., Styrylska M., Machowska B. Dysproteinemia u chorych na raka pluca przed i miesiac po operacji, (Dyspro-teinaemia in lung cancer patients prior to and a month after surgery). Diagn Lab, 1991, 27: 40–46.
  • Adamczyk B. Ocena wplywu wieku i plci oraz lokalizacji proce-su nowotworowego i jego nasilenia na ksztaltowanie sie zmian bialek surowicy krwi, (Influence of age and gender of patients, site and progression of malignant diseases on the changes in the serum protein composition). Nowotwory, 1981, 31: 31–46.
  • Kushner I., Rzewnicki D. L. The acute phase response: general aspects. Bailliere’s Clin Rheumat, 1994, 8: 513–530.
  • Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999, 340: 448–454.
  • Moshage H. Cytokines and hepatic acute phase response. J Path, 1997, 181: 257–266.
  • Biffl W. L., Moore E. E., Moore F. A., Peterson V. M. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg, 1996, 224: 647–664.
  • Cruishank A. M., Frazer W. D., Burns H. J. G., Van Damme J., Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci, 1990, 79: 161165.
  • Kolodziejski L., Duda K., Kubisz A., Lobaziewicz W., Komorowski A., Mizianty M. Wczesna pooperacyjna podaz immunoglobuliny ludzkiej IG 5S u chorych o podwyzszonym ryzyku poddanych rozleglym operacjom onkologicznym, (Prophylactic role of the intravenous immunoglobulin 5S administration in high-risk patients following extensive oncological surgery). Pol Przegl Chir, 2000, 72: 931–941.
  • Duda K., SoboN M., Mizianty M., Tarapacz J., Kubisz A., Kulpa J. Stçzenie bialka calkowitego i jego frakcji w surowicy krwi a bilans plynów w dobie operacji u chorych na raka pluca, (Total serum protein and protein fraction concentrations vs. fluid balance on the first postoperative day in patients with carcinoma of the lung). Pol Przegl Chir, 1997, 69: 372–377.
  • Kulpa J., Duda K., Stasik Z., Mizianty M., Tarapacz J., Kubisz A. Dysproteinemia przedoperacyjna a pooperacyjne zmiany skladu bialek surowicy krwi i diurezy u chorych na raka pluca, (Preoperative dysproteinaemia and postoperative changes in serum protein composition and diuresis in lung cancer patients). Diagn Lab, 1998, 34: 541–548.
  • Nicholson J. P., Wolmarans M. R., Park G. R. The role of albumin in critical illness. Brit J Anaesth, 2000, 85: 599–610.
  • Haupt W., Hohenberger W., Mueller R., Klein P., Christou N. V. Association between pre-operative acute phase response and postoperative complications. Eur J Surg, 1997, 163: 39–44.
  • Haupt W., Holtzheimer R. G., Riese J., Klein P., Hohenberger W. Association of low pre-operative serum albumin concentrations and acute phase response. Eur J Surg, 1999, 165: 307–313.
  • Smeets H. J., Kievit J., Dulfer F. T., Hermans J. O., Moolenaar A. J. Analysis of post-operative hypo-albuminaemia: a clinical study. Int Surg, 1994, 79: 152–157.
  • Schierhout G., Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. Brit Med J, 1998, 316: 961–964.
  • Grundmann R., von Lehndorff C. Zur Indikation der postoperativen Humanalbumintherapie auf der Intensivstation-Eine prospektiv randomisierte Studie. Langenbecks Arch Chir, 1986, 367: 235–246.
  • Erstad B. L., Gales B. J., Rappaport W. D. The use of albumin in clinical practice. Arch Int Med, 1991, 151: 901–911.
  • Natsch S., van Leeuwen S. J., de Jong R., Hekster Y. A. Use of albumin in intensive care unit patients-is continuous quality assessment necessary? J Clin Pharm Ther, 1998, 23: 179–183.
  • Erstad B. L. Concerns with defining appropriate uses of albumin by meta-analysis. Am J Health — Syst Pharm, 1999, 56: 14511454.
  • Hiesmayr M., Druml W. Gibt es noch Indikationen für Albumin? Wien klin Wochenschr, 1999, 111: 1–4.
  • Fergusson N. D., Stewart T. E., Etchells E. E. Human albumin administration in critically ill patients. Intens Care Med, 1999, 25: 323–325.
  • Choi P. T.-L., Yip G., Quinonez L. G., Cook D. J. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med, 1999, 27: 200–210.
  • LeNczyk M., Adamczyk B. Zachowanie sie bialka osocza w okresie pooperacyjnym u chorych na raka zoladka, (Changes of the plasma protein level during the postoperative period in the patients operated for carcinoma of the stomach). Pol Przegl Chir, 1969, 41: 1012–1016.
  • Falconer J. S., Fearon K. C. H., Ross J. A., Elton R., Wigmore S. J., Garden O. J., Carter D. C. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer, 1995, 75: 2077–2082.
  • Adamczyk B., Duda K., Bogacki W. Objętość krwi i stęŻenie oraz ilość białek krąŻących osocza u chorych na raka odbytnicy leczonych chirurgicznie, (Blood volume and concentration and the amount of plasma proteins in surgically treated patients with rectal carcinoma). Nowotwory, 1980, 30: 385–392.
  • Wilmore D. W. Metabolic response to severe surgical illness: overview. World J Surg, 2000, 24: 705–711.
  • Kim P. K., Deutschman C. S. Inflammatory responses and mediators. Surg Clin NAm, 2000, 80: 885–894.
  • Kaysen G. A., Rathore V., Shearer G. C., Depner T. A. Mechanisms of hypo-albuminemia in hemodialysis patients. Kidney Int., 1995, 48: 510–516.
  • Shetty P. S., Watrasiewicz K. E., Jung R. T., James W. P. T. Rapid turnover transport proteins: an index of subclinical protein-energy malnutrition. Lancet, 1979, 2: 230–232.
  • Thuillier E. Les marqueurs protéiques de l’état nutritionnel. Sem Hôp Paris, 1994, 70: 445–452.
  • Petersen S. R., Jeevanandam M., Shahbazian L. M., Holaday N. J. Reprioritization of liver protein synthesis resulting from recombinant human growth hormone supplementation in parenterally fed trauma patients: effect of growth hormone on the acute-phase response. J Trauma, 1997, 42: 987–994.
  • Sablotzki A., Mühling J., Dehne M. G., Zickman B., Silber R. E., Friedrich I. Treatment of sepsis in cardiac surgery: role of immunoglobulins. Perfusion, 2001, 16: 113–120.
  • Cafiero F., Gipponi M., Bonalumi U., Piccardo A., Sguotti Ch., Corbetta G. Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk of sepsis undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial. Surgery, 1992, 112: 24–31.
  • Rotschild M. A., Oratz M., Evans C., Schreiber S. S. Alterations in albumin metabolism after serum and albumin infusions. J Clin Invest, 1964, 43 (10): 1874–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.